Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Obstetrics & Gynaecology

Gynecologic Oncology

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

Gynecologic Oncology | Oct 18, 2019 Gynecologic Oncology

Race/ethnicity and accuracy of self-reported female first-degree family history of breast and other cancers in the Northern California Breast Cancer Family Registry

Cancer Epidemiology, Biomarkers & Prevention | Oct 18, 2019 Gynecologic Oncology

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

Journal of Pathology | Oct 18, 2019 Gynecologic Oncology

A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): A collaboration of MITO, AIRO GYN, and MaNGO Groups

The Oncologist | Oct 17, 2019 Gynecologic Oncology

Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study

Gynecologic Oncology | Oct 17, 2019 Gynecologic Oncology

Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial

Gynecologic Oncology | Oct 17, 2019 Gynecologic Oncology

A single-arm, phase 2 trial of combined bevacizumab and nivolumab in relapsed ovarian cancer

JAMA Oncology | Oct 16, 2019 Gynecologic Oncology

Birth weight, weight over the adult life course, and risk of breast cancer

International Journal of Cancer | Oct 15, 2019 Gynecologic Oncology

PI3K pathway effectors pAKT and FOXO1 as novel markers of endometrioid intraepithelial neoplasia

International Journal of Gynecologic Pathology | Oct 14, 2019 Gynecologic Oncology

Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow up

International Journal of Cancer | Oct 13, 2019 Gynecologic Oncology

« Prev 1 … 40 41 42 43 44 … 143 Next »

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

Race/ethnicity and accuracy of self-reported female first-degree family history of breast and other cancers in the Northern California Breast Cancer Family Registry

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): A collaboration of MITO, AIRO GYN, and MaNGO Groups

Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study

Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial

A single-arm, phase 2 trial of combined bevacizumab and nivolumab in relapsed ovarian cancer

Birth weight, weight over the adult life course, and risk of breast cancer

PI3K pathway effectors pAKT and FOXO1 as novel markers of endometrioid intraepithelial neoplasia

Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow up

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy

Race/ethnicity and accuracy of self-reported female first-degree family history of breast and other cancers in the Northern California Breast Cancer Family Registry

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): A collaboration of MITO, AIRO GYN, and MaNGO Groups

Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study

Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial

A single-arm, phase 2 trial of combined bevacizumab and nivolumab in relapsed ovarian cancer

Birth weight, weight over the adult life course, and risk of breast cancer

PI3K pathway effectors pAKT and FOXO1 as novel markers of endometrioid intraepithelial neoplasia

Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow up

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic